Effect of bupropion, an antidepressant drug, on Sniffing behavior has been examined in male rats. Animals treated intraperitoneally (i.p.) with different doses of bupropion (5-40 mg/kg), showed Sniffing behavior in a dose-related manner. Pretreatment of animals with the dopamine antagonists, SCH 23390 (0.025-0.1 mg/kg, Lp.) or sulpiride (12.5-50 mg/kg, i.p.) decreased the bupropion induced Sniffing. Reserpine pretreatment (2.5 mg/kg, i.p,18h) alone and in combination with alpha-methyl-p-tyrosine (AMPT; 250 mg/kg, i.p.) also reduced the bupropion induced Sniffing. The α-adrenoceptor antagonist, phenoxybenzamine (5 and 10 mg/kg, i.p.), the padrenoceptor antagonist, propranolol (5 and 10 mg/kg, Lp.) did not affect the bupropion induced response. The antimuscarinic, atropine (5 and 10 mg/kg, i.p.), increased the response significantly. It is concluded that bupropion induces Sniffing through indirect dopaminergic mechanism.